Early use of azathioprine in Crohn's disease

Gastroenterology

Volumn 146, Issue 3, 2014, Pages 865-866

  Hawthorne, A B ^a   Probert, C S J ^a   Sanderson, J D ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; CORTICOSTEROID; IMMUNOMODULATING AGENT;

CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DISEASE COURSE; FOLLOW UP; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

AZATHIOPRINE; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE;

EID: 84894354747     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.10.072     Document Type: Letter

References (8)

1. J. Cosnes et al. Gastroenterology 145 2013 758 765
2. J. Panes et al. Gastroenterology 145 2013 766 774
3. L. Beaugerie et al. Gastroenterology 130 2006 650 656
4. J. Cosnes et al. Gut 61 2012 1140 1145
5. D.P. O'Donoghue et al. Lancet 2 1978 955 957
6. M. Lemann et al. Gastroenterology 128 2005 1812 1818
7. A.V. Ramadas et al. Gut 59 2010 1200 1206
8. M.A. Smith et al. J Crohn's Colitis 6 2012 905 912